“…It is well established that a reduction in the threshold for SOICR, combined with an increase in SR load, enhances the propensity for SOICR which is commonly linked to arrhythmias (Jones et al ., ; Chen et al ., ; Jones et al ., ). We have found this to be a common mechanism contributing to how mutations within RyR2, oxidation, doxorubicin and methylxanthine derivatives such as aminophylline and theophylline all lead to arrhythmia (Jones et al ., ; Kong et al ., ; Hanna et al ., ; Waddell et al ., ). Although class I kinase inhibitors appear to have a strong agonist effect at the cell level, at the single channel, the effect is less clear cut.…”